Related Experiment Videos
Diagnostic disclosure: a tale in two cultures
P McDonald-Scott1, S Machizawa, H Satoh
1Department of Adult Psychiatry, National Institute of Mental Health, Ichikawa, Japan.
Psychological Medicine
|February 1, 1992
Summary
Psychiatrists in Japan and North America disclose diagnoses differently, especially for schizophrenia. Cultural views on patienthood influence diagnostic communication and family notification practices.
Area of Science:
- Psychiatry
- Cross-cultural psychology
- Medical ethics
Background:
- Diagnostic communication practices between physicians and patients are believed to vary significantly across cultures.
- Understanding these cross-cultural differences in disclosing psychiatric diagnoses is crucial for effective patient care and ethical practice.
Purpose of the Study:
- To investigate and compare diagnostic disclosure practices for psychiatric patients between Japanese and North American psychiatrists.
- To explore cultural influences on the communication of diagnoses, particularly for severe mental illnesses like schizophrenia.
Main Methods:
- A questionnaire survey was administered to practicing psychiatrists in Japan (N=166) and North America (N=112).
- The survey included six case vignettes to assess diagnostic disclosure decisions.
- Data were analyzed to compare disclosure rates and preferred communication strategies between the two cultural groups.
Main Results:
- High disclosure rates (>90%) for affective and anxiety disorders were observed in both Japan and North America.
- Significant differences emerged for schizophrenia/schizophreniform disorders: 70% of North American psychiatrists disclosed the diagnosis, compared to less than 30% of Japanese psychiatrists.
- Japanese psychiatrists favored vague diagnoses (e.g., neurasthenia), while North Americans discussed differential diagnoses.
- Family notification was common in both cultures, but North Americans required patient consent.
Conclusions:
- Diagnostic disclosure is culturally influenced, particularly for conditions with uncertain prognoses or significant stigma, such as schizophrenia.
- Effective treatments correlate with higher disclosure rates across cultures.
- Culturally constructed views of patienthood significantly shape diagnostic disclosure practices.